| 1207604 |
Germany |
PROOF-ACS GmbH
PROOF-ACS GmbH
|
P2538-RT - Organic contaminants in leaching (soil)
P2538-RT - Organic contaminants in leaching (soil)
|
2025-11-03 |
|
|
| Remarks |
(soil (2:1, filtrated) is provided as test material. The eluate is spiked with a selection of organic) |
|
| 1353416 |
Germany |
Berufsverband Deutscher Humangenetiker e.V.
Berufsverband Deutscher Humangenetiker e.V.
|
Tumour cytogenetics
[Tumorzytogenetik]
Tumour cytogenetics
[Tumorzytogenetik]
|
2025-04-23 |
|
|
| Remarks |
(participation in the EQA test.
Certificate: A certificate will be provided that states the (successful) |
|
| 1353422 |
Germany |
Berufsverband Deutscher Humangenetiker e.V.
Berufsverband Deutscher Humangenetiker e.V.
|
Genetic counseling
[Genetische Beratung]
Genetic counseling
[Genetische Beratung]
|
2025-04-23 |
|
|
| Remarks |
(information (e.g. checklist and a list with relevant reference points/criteria) will be provided on the BVDH) |
|
| 1353440 |
Germany |
Berufsverband Deutscher Humangenetiker e.V.
Berufsverband Deutscher Humangenetiker e.V.
|
NGS: Molecular analysis of constitutional variants
[NGS: Molekulare Analyse von konstitutionellen Varianten]
NGS: Molecular analysis of constitutional variants
[NGS: Molekulare Analyse von konstitutionellen Varianten]
|
2025-04-23 |
|
|
| Remarks |
(. The variant table will be available for download. A short anamnesis will be provided.
Method: The) |
|
| 1444339 |
Germany |
PROOF-ACS GmbH
PROOF-ACS GmbH
|
P2602-MRT Collecting field samples
P2602-MRT Collecting field samples
|
2025-11-03 |
|
|
| Remarks |
(documentation of sampling, provided that the participant is accredited for this.) |
|
| 142554 |
United Kingdom |
Weqas
Weqas
|
BNP
[BNP]
BNP
[BNP]
|
2024-09-24 |
|
|
| Remarks |
(). Separate samples are provided for BNP and NT-proBNP. PoCT devices are assessed separately to laboratory) |
|
| 1445199 |
Germany |
PROOF-ACS GmbH
PROOF-ACS GmbH
|
P2607-MRT MOSH/MOAH in emulsifiers (LC-GC-FID and GCxGC-FID)
P2607-MRT MOSH/MOAH in emulsifiers (LC-GC-FID and GCxGC-FID)
|
2025-11-10 |
|
|
| Remarks |
(asked to provide the chromatograms and plots related to the test materials.
the participants are asked) |
|
| 1349734 |
Germany |
Berufsverband Deutscher Humangenetiker e.V.
Berufsverband Deutscher Humangenetiker e.V.
|
NGS: Bioinformatics
[NGS: Bioinformatik]
NGS: Bioinformatics
[NGS: Bioinformatik]
|
2025-04-10 |
|
|
| Remarks |
(analysis are provided in a .bed file, all analysis must be restricted to the regions specified in the) |
|
| 1445746 |
Germany |
PROOF-ACS GmbH
PROOF-ACS GmbH
|
P2626-MRT - NMR-Profiling in honey
P2626-MRT - NMR-Profiling in honey
|
2025-11-04 |
|
|
| Remarks |
(provided for analysis:
- a blossom honey (country of origin and botanical variety will be announced) |
|
| 193523 |
Italy |
QUALITYCHECK S.r.l.s.
QUALITYCHECK S.r.l.s.
|
Microbiological parameters in drinking water
[Parametri microbiologici in acqua destinata al consumo umano ]
Microbiological parameters in drinking water
[Parametri microbiologici in acqua destinata al consumo umano ]
|
2023-08-25 |
|
|
| PT provider ID |
(192704) |
| Remarks |
(Qualitycheck is a Proficiency Testing Provider that operates according to the international) |
|
| 212154 |
Germany |
DRRR - Deutsches Referenzbüro für Ringversuche und Referenzmaterialien GmbH
DRRR - Deutsches Referenzbüro für Ringversuche und Referenzmaterialien GmbH
|
TOYS
[SPIELZEUG]
TOYS
[SPIELZEUG]
|
2025-11-03 |
|
|
| Remarks |
(desired and only allowed to a certain extent. This PT scheme enables the participating) |
|
| 455071 |
Brazil |
KYMI LTDA
KYMI LTDA
|
KYMI FePT
[KYMI FePT]
KYMI FePT
[KYMI FePT]
|
2018-02-05 |
|
|
| Remarks |
(Calculations based on ISO standards. For PT scores, the Scheme follows ISO 13528. Target values for) |
|
| 858643 |
Germany |
Reference Institute for Bioanalytics
Reference Institute for Bioanalytics
|
Molecular genetics group 2
[Molekulargenetik Gruppe 2]
Molecular genetics group 2
[Molekulargenetik Gruppe 2]
|
2021-04-28 |
|
|
| Remarks |
(Genetics Quality Network (EMQN). More information: www.rfb.bio/pdf/EMQN.pdf
This PT is intended for) |
|
| 858594 |
Germany |
Reference Institute for Bioanalytics
Reference Institute for Bioanalytics
|
circulating tumor DNA
[circulating tumor DNA]
circulating tumor DNA
[circulating tumor DNA]
|
2021-04-26 |
|
|
| Remarks |
(survey is not subject of the accreditated area of the RfB.
This PT is intended for medical) |
|
| 858589 |
Germany |
Reference Institute for Bioanalytics
Reference Institute for Bioanalytics
|
Semen analysis
[Spermatologie]
Semen analysis
[Spermatologie]
|
2021-04-26 |
|
|
| Remarks |
(subject of the accreditated area of the RfB.
This PT is intended for medical laboratories.
The) |
|
| 824020 |
Germany |
Reference Institute for Bioanalytics
Reference Institute for Bioanalytics
|
Allergology
[Allergologie]
Allergology
[Allergologie]
|
2021-02-18 |
|
|
| Remarks |
(This PT is intended for medical laboratories.
The volume of the specimens can be different) |
|
| 854343 |
Germany |
Reference Institute for Bioanalytics
Reference Institute for Bioanalytics
|
Toxicologic analyses
[Toxikologische Analyse]
Toxicologic analyses
[Toxikologische Analyse]
|
2021-04-12 |
|
|
| Remarks |
(essential to succeed in this survey.
This PT is intended for medical laboratories.
The Reference) |
|
| 915279 |
Paraguay |
INTELECTOPY S.A.
INTELECTOPY S.A.
|
Vehicle Technical Inspection in vehicles of category M / N/ L/O.
[Inspección Técnica Vehícular en vehículos de categoría N/O/M]
Vehicle Technical Inspection in vehicles of category M / N/ L/O.
[Inspección Técnica Vehícular en vehículos de categoría N/O/M]
|
2024-07-22 |
|
|
| Remarks |
(The purpose of this PT is to verify the quality of the inspections carried out on motor vehicles in) |
|
| 667234 |
Australia |
National Measurement Institute, Australia
National Measurement Institute, Australia
|
PFAS Total Oxidisable / Oxidizable Precursor (TOP) Assay
PFAS Total Oxidisable / Oxidizable Precursor (TOP) Assay
|
2026-03-13 |
|
|
| Remarks |
(all samples in several NMI PT studies ahead of time.
Please email proficiency@measurement.gov.au for more information.) |
|
| 142678 |
United Kingdom |
Weqas
Weqas
|
POCT INR
[POCT INR]
POCT INR
[POCT INR]
|
2024-05-21 |
|
|
| Remarks |
(based on a standardised ratio of the patient’s Prothrombin time, (PT) versus a normal control) (sample. Therefore, the INR of a healthy individual not on anticoagulation therapy would be 1.0.
PT) |
|
